Franz J. Zemp

3.1k citations
40 papers · 2.3k indexed · h-index 26
Topics
Virus-based gene therapy research (10 papers)CAR-T cell therapy research (8 papers)MicroRNA in disease regulation (6 papers)

In The Last Decade

Franz J. Zemp

39 papers receiving 2.2k citations

Peers

Franz J. Zemp
Comparison fields: 5 of 119
  • Molecular Biology 1.0k
  • Immunology 651
  • Genetics 466
  • Oncology 457
  • Cancer Research 362
Replace Egbert Flory with:
Egbert Flory Germany
Kate L. Jeffrey United States
José A. García‐Sanz Spain
Jacob Giehm Mikkelsen Denmark
Ari Hinkkanen Finland
Peter A. Schweitzer United States
Jorge L. Martínez‐Torrecuadrada Spain
Pinaki P. Banerjee United States
F. Nina Papavasiliou United States
Brian C. Schaefer United States
Franz J. Zemp relative to Egbert Flory Germany Egbert Flory's profile →
Citations per field
00.5×1.6×
Egbert Flory · 1×
Citations per year

Countries citing papers authored by Franz J. Zemp

Since Specialization
Citations

This map shows the geographic impact of Franz J. Zemp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franz J. Zemp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franz J. Zemp more than expected).

Fields of papers citing papers by Franz J. Zemp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franz J. Zemp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franz J. Zemp. The network helps show where Franz J. Zemp may publish in the future.

Co-authorship network of co-authors of Franz J. Zemp

This figure shows the co-authorship network connecting the top 25 collaborators of Franz J. Zemp. A scholar is included among the top collaborators of Franz J. Zemp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franz J. Zemp. Franz J. Zemp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 1
3 1
4 7
5 6
6 53
7 56
8 41
9 52
10 28
11 165
12 49
13 4
14 65
15 2
16 89
17 47
18 25
19 50
20 63

About Franz J. Zemp

Franz J. Zemp is a scholar working on Immunology, Developmental Neuroscience and Cancer Research, having authored 40 papers that have together received 2.3k indexed citations. Recurring topics across this work include Virus-based gene therapy research (10 papers), CAR-T cell therapy research (8 papers) and MicroRNA in disease regulation (6 papers). The work is most often cited by research in Immunology (651 citations), Cancer Research (362 citations) and Oncology (457 citations). Franz J. Zemp has collaborated with scholars based in Canada, United States and Netherlands. Frequent co-authors include Olga Kovalchuk, Peter Forsyth, Igor Kovalchuk, Igor P. Pogribny, Grant McFadden, Igor Koturbash, Paul Kubes, Masmudur M. Rahman, Alexander Boyko and Craig N. Jenne. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026